A glycolytic molecule called aldehyde dehydrogenase (ALDH) has been linked to the metabolic dysregulation of GBM, and increased expression of ALDH has been demonstrated to increase tumor aggressiveness (50). This evidence concerns the gene LDHA and neoplasm.